Ammar Waham Ashor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ammar Waham Ashor has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Mario Siervo
Dementia Centre of Excellence, School of Population Health, Curtin University, Perth 6102, Australia
21 shared publications - John Cummings Mathers
Human Nutrition and Exercise Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK
12 shared publications Clio Oggioni
Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Campus for Ageing and Vitality, Newcastle on Tyne, NE4 5PL, UK
9 shared publicationsJose Lara
9 shared publicationsJohn C. Mathers
Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, William Leech Building, Framlington Place, Newcastle upon Tyne, NE2 4HH, United Kingdom
6 shared publications- Kirsten Brandt
Human Nutrition & Exercise Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
5 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2026 (1)
Severe agranulocytosis in patient with Graves’ disease on second exposure to carbimazole
Summary: For half a century, antithyroid drugs (ATDs) have been the first-line treatment for Graves’ disease. ATDs, e.g. carbimazole, are associated with minor and serious adverse effects. These include rash, urticaria, arthralgia, hepatotoxicity, vasculitis, and agranulocytosis. Agranulocytosis is a potentially serious adverse effect characterised by a neutrophil count <0.5 × 109 cells/L, which may deteriorate further into sepsis and death. This is a case report of a 47-year-old female who had a 17-year history of Graves’ disease. She received carbimazole for 2 years, which was stopped after remission. She presented with relapsed thyrotoxicosis in 2025 when carbimazole (40 mg) was reinstituted. Three weeks later, the patient self-presented to the hospital with sore throat, painful swallowing, and sweating. Examination found oral ulceration, pharyngeal erythema, and tender cervical lymphadenopathy. She was admitted to the hospital and treated under the endocrinology team as agranulocytosis, carbimazole was stopped, and she was treated per local guidelines of neutropenic sepsis. After agranulocytosis was resolved, the patient underwent total thyroidectomy. Despite being well-tolerated, doctors and patients should be well aware of this potentially serious adverse effect of carbimazole. Learning points:
- 1 January 2026
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2026 (1)
Open AccessSevere agranulocytosis in patient with Graves’ disease on second exposure to carbimazole
Summary: For half a century, antithyroid drugs (ATDs) have been the first-line treatment for Graves’ disease. ATDs, e.g. carbimazole, are associated with minor and serious adverse effects. These include rash, urticaria, arthralgia, hepatotoxicity, vasculitis, and agranulocytosis. Agranulocytosis is a potentially serious adverse effect characterised by a neutrophil count <0.5 × 109 cells/L, which may deteriorate further into sepsis and death. This is a case report of a 47-year-old female who had a 17-year history of Graves’ disease. She received carbimazole for 2 years, which was stopped after remission. She presented with relapsed thyrotoxicosis in 2025 when carbimazole (40 mg) was reinstituted. Three weeks later, the patient self-presented to the hospital with sore throat, painful swallowing, and sweating. Examination found oral ulceration, pharyngeal erythema, and tender cervical lymphadenopathy. She was admitted to the hospital and treated under the endocrinology team as agranulocytosis, carbimazole was stopped, and she was treated per local guidelines of neutropenic sepsis. After agranulocytosis was resolved, the patient underwent total thyroidectomy. Despite being well-tolerated, doctors and patients should be well aware of this potentially serious adverse effect of carbimazole. Learning points:
- Open Access
- 28 September 2024
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 74 (10 (Supple) , S111-S118
The Effect of Tocilizumab on the outcome of patients with severe COVID-19 with cytokine storm syndrome in a sample of Iraqi patients
Objective: To determine whether tocilizumab improved outcomes of patients hospitalised with severe coronavirusdisease-2019 cytokine storm syndrome.Method: The case-control study was conducted at Al-Yarmouk Teaching Hospital, Baghdad, and Al Shatra GeneralHospital, Thi Qar, Iraq, from September 2020 to March 2021, and comprised patients with severe acquiredrespiratory syndrome-corona virus-2 pneumonia who were not candidates for mechanical ventilation and receiveda single-dose intravenous infusion of tocilizumab 8mg/kg in group A. The outcomes were compared with patientsin group B who received only standard care. Data was analysed using SPSS 26.Results: Of the 60 patients, 30(50%) were in group A; 22(73.3%) males and 8(26.7%) females with mean age56.63±10.92 years. There were 30(50%) patients in control group B; 24(80%) males and 6(20%) females with meanage 54.8±6.18 (p>0.05). Group A showed significant changes compared to group B in the levels of interleukin-6,serum ferritin, D-dimer, procalcitonin, lymphocytes count and oxygen saturation (p0.05).Conclusions: Majority of the acute phase inflammatory markers were reduced significantly by treatment withtocilizumab.Key Words: Tocilizumab, fibrin, Interleukin, Procalcitonin, Cytokine, Infusions, Intravenous, Oxygen Saturation,Respiration, Artificial, Coronavirus, Lymphocytes, Ferritins
- 28 September 2024
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 74 (10 (Supple) , S111-S118
Open AccessThe Effect of Tocilizumab on the outcome of patients with severe COVID-19 with cytokine storm syndrome in a sample of Iraqi patients
Objective: To determine whether tocilizumab improved outcomes of patients hospitalised with severe coronavirusdisease-2019 cytokine storm syndrome.Method: The case-control study was conducted at Al-Yarmouk Teaching Hospital, Baghdad, and Al Shatra GeneralHospital, Thi Qar, Iraq, from September 2020 to March 2021, and comprised patients with severe acquiredrespiratory syndrome-corona virus-2 pneumonia who were not candidates for mechanical ventilation and receiveda single-dose intravenous infusion of tocilizumab 8mg/kg in group A. The outcomes were compared with patientsin group B who received only standard care. Data was analysed using SPSS 26.Results: Of the 60 patients, 30(50%) were in group A; 22(73.3%) males and 8(26.7%) females with mean age56.63±10.92 years. There were 30(50%) patients in control group B; 24(80%) males and 6(20%) females with meanage 54.8±6.18 (p>0.05). Group A showed significant changes compared to group B in the levels of interleukin-6,serum ferritin, D-dimer, procalcitonin, lymphocytes count and oxygen saturation (p0.05).Conclusions: Majority of the acute phase inflammatory markers were reduced significantly by treatment withtocilizumab.Key Words: Tocilizumab, fibrin, Interleukin, Procalcitonin, Cytokine, Infusions, Intravenous, Oxygen Saturation,Respiration, Artificial, Coronavirus, Lymphocytes, Ferritins
- Open Access
- 23 July 2022
- Published by Springer Nature in European Journal of Nutrition
- Vol. 61 (8) , 4191-4203
Double-blind controlled dietary cross-over intervention with differentially fertilised intact lettuce leaves shows acute reduction in blood pressure in young adults, associated with faster uptake of nitrate than of phenolics
Purpose: To compare acute effects on blood pressure (BP) of ingestion of visually similar lettuce with controlled high and low content of either nitrate or phenolic compounds. Methods: In a randomised cross-over design, 19 healthy participants (22–31 years) received 50 g of lettuce containing either 530 mg (8.4 mmol) nitrate + 11 mg (0.03 mmol) phenolic compounds (HNLP); or 3 mg nitrate (0.05 mmol) + 77 mg (0.2 mmol) phenolic compounds (LNHP), obtained by differential fertilisation. Ambulatory BP was recorded along with plasma, salivary and urinary nitrate and nitrite and plasma concentrations of cyclic guanosine monophosphate (cGMP), phenolic metabolites, Trolox equivalent antioxidant capacity (TEAC) and ferric reducing antioxidant power (FRAP). Results: Compared with LNHP, 3 h post ingestion of HNLP, plasma nitrate increased 0.31 ± (95%CI) 0.12 mM (+ 240%), and salivary nitrate 5.5 ± 1.4 mM (+ 910%); accumulated urinary nitrate excretion increased 188 ± 72 mg (+ 296%) (all P < 0.001). Systolic BP was reduced 4.9 ± 4.2 mmHg (P = 0.031) between 3 and 6 h after ingestion of HNLP compared with LNHP; systolic BP differences were negatively correlated (P = 0.004) with differences in saliva nitrate concentrations. LNHP increased plasma phenolics at 6 h, predominantly 3ʹ-methoxycinnamic acid-4ʹ-glucuronide (ferulic acid-4ʹ-glucuronide), 116%, 204 ± 138 nM more than HNLP (P = 0.001); increased cGMP 14% (P = 0.019); and reduced FRAP 3.1% (P = 0.009). Conclusion: The acute BP difference within 6 h of consumption matched the plasma/saliva nitrate peak, not the slower changes of plasma phenolics. This is the first double-blind controlled dietary intervention demonstrating differential effects on human physiology by consumption of an intact plant food, where compositional differences were obtained by controlling growing conditions, indicating potential opportunities for health claims relating to precision/vertical farming. Clinical trial registration: The trial was retrospectively registered on ClinicalTrials.gov, with identifier NCT02701959, on March 8, 2016.
- 23 July 2022
- Published by Springer Nature in European Journal of Nutrition
- Vol. 61 (8) , 4191-4203
Open AccessDouble-blind controlled dietary cross-over intervention with differentially fertilised intact lettuce leaves shows acute reduction in blood pressure in young adults, associated with faster uptake of nitrate than of phenolics
Purpose: To compare acute effects on blood pressure (BP) of ingestion of visually similar lettuce with controlled high and low content of either nitrate or phenolic compounds. Methods: In a randomised cross-over design, 19 healthy participants (22–31 years) received 50 g of lettuce containing either 530 mg (8.4 mmol) nitrate + 11 mg (0.03 mmol) phenolic compounds (HNLP); or 3 mg nitrate (0.05 mmol) + 77 mg (0.2 mmol) phenolic compounds (LNHP), obtained by differential fertilisation. Ambulatory BP was recorded along with plasma, salivary and urinary nitrate and nitrite and plasma concentrations of cyclic guanosine monophosphate (cGMP), phenolic metabolites, Trolox equivalent antioxidant capacity (TEAC) and ferric reducing antioxidant power (FRAP). Results: Compared with LNHP, 3 h post ingestion of HNLP, plasma nitrate increased 0.31 ± (95%CI) 0.12 mM (+ 240%), and salivary nitrate 5.5 ± 1.4 mM (+ 910%); accumulated urinary nitrate excretion increased 188 ± 72 mg (+ 296%) (all P < 0.001). Systolic BP was reduced 4.9 ± 4.2 mmHg (P = 0.031) between 3 and 6 h after ingestion of HNLP compared with LNHP; systolic BP differences were negatively correlated (P = 0.004) with differences in saliva nitrate concentrations. LNHP increased plasma phenolics at 6 h, predominantly 3ʹ-methoxycinnamic acid-4ʹ-glucuronide (ferulic acid-4ʹ-glucuronide), 116%, 204 ± 138 nM more than HNLP (P = 0.001); increased cGMP 14% (P = 0.019); and reduced FRAP 3.1% (P = 0.009). Conclusion: The acute BP difference within 6 h of consumption matched the plasma/saliva nitrate peak, not the slower changes of plasma phenolics. This is the first double-blind controlled dietary intervention demonstrating differential effects on human physiology by consumption of an intact plant food, where compositional differences were obtained by controlling growing conditions, indicating potential opportunities for health claims relating to precision/vertical farming. Clinical trial registration: The trial was retrospectively registered on ClinicalTrials.gov, with identifier NCT02701959, on March 8, 2016.
- 1 December 2021
- Vol. 71 (12) , S72-S76
The correlation of pro- and anti-inflammatory markers with glycaemic indices in healthy participants and in patients with type 2 diabetes mellitus
Objectives: To investigate the association of high-sensitivity C-reactive protein and adiponectin with glycaemic indices in healthy, prediabetes and diabetes patients. Method: The prospective cross-sectional study was conducted from June 2018 to February 2019 at the National Diabetes Centre and the Al-Kindi Specialised Centre for Endocrinology and Diabetes, Baghdad, Iraq, and comprised adult subjects of either gender who were normoglycaemic, those with impaired fasting blood glucose and glycated haemoglobin levels and newly-diagnosed patients of type 2 diabetes. Anthropometric measurements biochemical investigations were done for each subject. Data was analysed using SPSS 25. Results: Of the 80 subjects, 20(25%) were in the normoglycaemia group with a mean age of 48.8 +/- 11.9 years; 9(45%) males and 11(55%) females. Another 20(25%) were in the prediabetes group with a mean age of 52.0 +/- 5.7 years; 9(45%) males and 11(55%) females. Besides, there were 40(50%) diabetes patients with a mean age of 50.6 +/- 6.9 years; 18(45%) males and 22(55%) females (p>0.05). Adiponectin concentration was significantly lower and high-sensitivity C-reactive protein was significantly higher in the patient group compared to the other two groups (p<0.001). There was a significantly negative correlation of adiponectin concentration and significantly positive correlation of high-sensitivity C-reactive protein with fasting blood sugar and glycated haemoglobin (p<0.001). Conclusions: Poor glycaemic control was associated with higher pro-inflammatory and lower anti-inflammatory markers.
- 1 December 2021
- Vol. 71 (12) , S72-S76
The correlation of pro- and anti-inflammatory markers with glycaemic indices in healthy participants and in patients with type 2 diabetes mellitus
Objectives: To investigate the association of high-sensitivity C-reactive protein and adiponectin with glycaemic indices in healthy, prediabetes and diabetes patients. Method: The prospective cross-sectional study was conducted from June 2018 to February 2019 at the National Diabetes Centre and the Al-Kindi Specialised Centre for Endocrinology and Diabetes, Baghdad, Iraq, and comprised adult subjects of either gender who were normoglycaemic, those with impaired fasting blood glucose and glycated haemoglobin levels and newly-diagnosed patients of type 2 diabetes. Anthropometric measurements biochemical investigations were done for each subject. Data was analysed using SPSS 25. Results: Of the 80 subjects, 20(25%) were in the normoglycaemia group with a mean age of 48.8 +/- 11.9 years; 9(45%) males and 11(55%) females. Another 20(25%) were in the prediabetes group with a mean age of 52.0 +/- 5.7 years; 9(45%) males and 11(55%) females. Besides, there were 40(50%) diabetes patients with a mean age of 50.6 +/- 6.9 years; 18(45%) males and 22(55%) females (p>0.05). Adiponectin concentration was significantly lower and high-sensitivity C-reactive protein was significantly higher in the patient group compared to the other two groups (p<0.001). There was a significantly negative correlation of adiponectin concentration and significantly positive correlation of high-sensitivity C-reactive protein with fasting blood sugar and glycated haemoglobin (p<0.001). Conclusions: Poor glycaemic control was associated with higher pro-inflammatory and lower anti-inflammatory markers.
- Open Access
- 1 December 2021
- Published by Enviro Research Publishers in Current Research in Nutrition and Food Science Journal
- Vol. 9 (3) , 945-952
The Association of Higher Composite Biomarker Score of Antioxidant Vitamins with Lower Cardiovascular Diseases Risk: A Cross-Sectional Study
- 1 December 2021
- Published by Enviro Research Publishers in Current Research in Nutrition and Food Science Journal
- Vol. 9 (3) , 945-952
Open AccessThe Association of Higher Composite Biomarker Score of Antioxidant Vitamins with Lower Cardiovascular Diseases Risk: A Cross-Sectional Study
- 1 July 2017
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 35 (7) , 1353-1359
Medium-term effects of dietary nitrate supplementation on systolic and diastolic blood pressure in adults
Dietary nitrate supplementation has been shown to lower blood pressure (BP) particularly in short-term clinical trials. Whether these effects are sustained in the long-term remains to be established. The objective was to conduct a meta-analysis of randomized controlled trials that examined whether dietary nitrate supplementation for more than 1 week has beneficial effects on SBP and DBP. Electronic databases were searched from inception until May 2016. Specific inclusion criteria were duration at least 1 week, report of effects on SBP or DBP or both and comparison of inorganic nitrate or beetroot juice supplementation with placebo control groups. Random-effects models were used to calculate the pooled BP effect sizes. Thirteen trials met eligibility criteria. The trials included a total of 325 participants with seven to 65 participants per study. The duration of each intervention ranged from 1 to 6 weeks. Ten trials assessed BP in resting clinic conditions, whereas 24-h ambulatory and daily home monitorings were used in six and three trials, respectively. Overall, dietary nitrate was associated with a significant decline in SBP [−4.1 mmHg (95% confidence interval: −6.1, −2.2); P < 0.001] and DBP [−2.0 mmHg (95% confidence interval: −3.0, −0.9); P < 0.001]. However, the effect was only significant when measured in resting clinical settings as no significant changes in BP were observed using 24-h ambulatory and daily home BP monitorings. Positive effects of medium-term dietary nitrate supplementation on BP were only observed in clinical settings, which were not corroborated by more accurate methods such as 24-h ambulatory and daily home monitorings.
- 1 July 2017
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 35 (7) , 1353-1359
Medium-term effects of dietary nitrate supplementation on systolic and diastolic blood pressure in adults
Dietary nitrate supplementation has been shown to lower blood pressure (BP) particularly in short-term clinical trials. Whether these effects are sustained in the long-term remains to be established. The objective was to conduct a meta-analysis of randomized controlled trials that examined whether dietary nitrate supplementation for more than 1 week has beneficial effects on SBP and DBP. Electronic databases were searched from inception until May 2016. Specific inclusion criteria were duration at least 1 week, report of effects on SBP or DBP or both and comparison of inorganic nitrate or beetroot juice supplementation with placebo control groups. Random-effects models were used to calculate the pooled BP effect sizes. Thirteen trials met eligibility criteria. The trials included a total of 325 participants with seven to 65 participants per study. The duration of each intervention ranged from 1 to 6 weeks. Ten trials assessed BP in resting clinic conditions, whereas 24-h ambulatory and daily home monitorings were used in six and three trials, respectively. Overall, dietary nitrate was associated with a significant decline in SBP [−4.1 mmHg (95% confidence interval: −6.1, −2.2); P < 0.001] and DBP [−2.0 mmHg (95% confidence interval: −3.0, −0.9); P < 0.001]. However, the effect was only significant when measured in resting clinical settings as no significant changes in BP were observed using 24-h ambulatory and daily home BP monitorings. Positive effects of medium-term dietary nitrate supplementation on BP were only observed in clinical settings, which were not corroborated by more accurate methods such as 24-h ambulatory and daily home monitorings.
- Open Access
- 31 May 2017
- Published by Taylor & Francis in International Journal of Food Sciences and Nutrition
- Vol. 69 (1) , 74-83
Dietary nitrate does not modify blood pressure and cardiac output at rest and during exercise in older adults: a randomised cross-over study
Dietary nitrate (NO3-) supplementation has been associated with improved vascular and metabolic health. We conducted a double-blind, cross-over, placebo-controlled RCT to investigate the effects of 7-d consumption of beetroot juice compared with placebo on (1) blood pressure (BP) measured in resting conditions and during exercise, (2) cardiac and peripheral vascular function and (3) biomarkers of inflammation, oxidative stress and endothelial integrity. Twenty non-smoking healthy participants aged 60–75 years and BMI 20.0–29.9 kg/m2 were recruited. Measurement was conducted before and after each 7-d intervention period. Consumption of NO3- had no effect on resting systolic and diastolic BP. NO3- consumption did not improve indexes of central and peripheral cardiac function responses during cardiopulmonary exercise testing. Dietary NO3- supplementation did not modify biomarkers of inflammation, oxidative stress and endothelial integrity. This study does not support the short-term benefits of dietary NO3- supplementation on physiological and biochemical markers of vascular health in older healthy adults. Graphical Abstract
- 31 May 2017
- Published by Taylor & Francis in International Journal of Food Sciences and Nutrition
- Vol. 69 (1) , 74-83
Open AccessDietary nitrate does not modify blood pressure and cardiac output at rest and during exercise in older adults: a randomised cross-over study
Dietary nitrate (NO3-) supplementation has been associated with improved vascular and metabolic health. We conducted a double-blind, cross-over, placebo-controlled RCT to investigate the effects of 7-d consumption of beetroot juice compared with placebo on (1) blood pressure (BP) measured in resting conditions and during exercise, (2) cardiac and peripheral vascular function and (3) biomarkers of inflammation, oxidative stress and endothelial integrity. Twenty non-smoking healthy participants aged 60–75 years and BMI 20.0–29.9 kg/m2 were recruited. Measurement was conducted before and after each 7-d intervention period. Consumption of NO3- had no effect on resting systolic and diastolic BP. NO3- consumption did not improve indexes of central and peripheral cardiac function responses during cardiopulmonary exercise testing. Dietary NO3- supplementation did not modify biomarkers of inflammation, oxidative stress and endothelial integrity. This study does not support the short-term benefits of dietary NO3- supplementation on physiological and biochemical markers of vascular health in older healthy adults. Graphical Abstract